Últimas noticias sobre ProKidney (NASDAQ:PROK) Bolsa

ProKidney

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

ProKidney Corp. - Class A Ordinary Shares

ProKidney Corp

Retirement should be a time of financial peace, not stress; yet, for many soon-to-be retirees, the transition from <a href="https://www.benzinga.com/news/24/08/40147003/rich-dad-poor-dad-author-robert-kiyosaki-sees-wealth-accumulation-in-market-declines-markets-are-cra">wealth accumulation</a> to income generation can be challenging.
The pressure to restructure the portfolio, ensuring it generates sufficient <a href="https://www.benzinga.com/personal-finance/25/03/44461718/high-income-earner-with-3000-monthly-to-invest-faces-big-decision-i-definitely-want-to-diversify-beyond-ai-and-dividends">income</a> to live comfortably, is immense, more so when market volatility looms. For those with low-risk tolerance, the task is even more daunting because the wrong move could mean returning to work or cutting back on living expenses drastically.
Don't Miss:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
</ul>
A Redditor has shared in a post that he&#8217;s faced with this exact challenge. With just eight months until retirement, the investor, a 62-year-old, has $400,000 to invest and is looking for maximal monthly dividend income with minimal risk.
Although this income won&#8217;t be his primary retirement funding but extra lifestyle cash to supplement his pension, the pressure to restructure his allocations wisely is immense for the poster.
&#8220;I&#8217;m in an odd spot due to exiting a business as a founder. My retirement scenario gets better every year. If I ever need extra cash, it will be in the first 5 years. I have a low-risk tolerance. Or, God forbid, I would need to go back to work if it crashed! It looks like we are in a dip now, obviously a high rate environment. Would this qualify as a better time to buy?&#8221; the investor wrote.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
The responses to his post ranged from ultra-conservative to moderately aggressive, so let&#8217;s analyze them.
<h2 class="wp-block-heading">Soon-to-be Retiree Has $400,000 to Invest for Dividend Income–Reddit Weights In</h2>
Invest in High-Quality Dividend ETFs
Considering the investor&#8217;s low-risk approach, Redditors suggested he pick a few high-quality ETFs to invest in.
&#8220;[Schwab U.S. Dividend Equity ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schd#NYSE">SCHD</a>)] gets you a decent amount,&#8221; a comment reads.
&#8220;[NEOS S&amp;P 500 High Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spyi#NYSE">SPYI</a>)] and chill,&#8221; says a Redditor, to which another user replied, &#8220;One advantage of SPYI is that its dividends are mainly return of capital. So, the tax is lower than an unqualified dividend from, say a [business development company]. However, if you use a tax-advantaged account like the Roth, that doesn&#8217;t matter.&#8221;
A commenter mentioned he splits his portfolio between two ETFs.
&#8220;I split between SPYI and [JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jepq#NASDAQ">JEPQ</a>)​],&#8221; he said.
&#8220;[​JPMorgan Equity Premium Income ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jepi#NYSE">JEPI</a>)​], JEPQ, [WP Carey (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wpc#NYSE">WPC</a>)], [Enterprise Products Partners LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/epd#NYSE">EPD</a>)], [MPLX LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mplx#NYSE">MPLX</a>)], SPYI,&#8221; an allocation suggestion reads.
A Reddit user wrote that this favorite individual stock of many investors is the perfect choice since it generates a 7% dividend yield per year.
&#8220;[Altria Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>)] &#8211; recession resistant, 7% yield. Your $400,000 would kick out $28,000 a year in income,&#8221; he said.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Go For Higher-Yielding Income Plays
Several Redditors suggested business development companies and covered-call ETFs since they deliver around 8% to 11% yields if the investor can handle a bit of risk.
&#8220;High-quality [business development companies] like [Ares Capital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arcc#NASDAQ">ARCC</a>)​], [Blue Owl Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/obdc#NYSE">OBDC</a>)], [Golub Capital BDC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbdc#NASDAQ">GBDC</a>)], [Blackstone Secured Lending Fund (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bxsl#NYSE">BXSL</a>)], [Main Street Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/main#NYSE">MAIN</a>)], [Capital Southwest Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cswc#NASDAQ">CSWC</a>)], [Fidus Investment Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fdus#NASDAQ">FDUS</a>)]. Average 9% yield,&#8221; a user recommended.
&#8220;[Business development companies] are a solid income-producing asset. This person doesn&#8217;t have decades to wait for growth. They need the money now as they are about to retire and growth was presumably the focus for the past few decades,&#8221; an advocate for business development companies wrote.
A Redditor shared in the comments that he&#8217;s been retired for 15 years and has the biggest part of his portfolio in high-yield business development companies.
&#8220;I&#8217;m 78 and have been retired for 15 years. I&#8217;m fortunate that social security and pensions cover my living expenses. The majority of my portfolio is high-yield [business development companies], [closed-end funds], and [real estate investment trusts]. The average yield is a tad over 10%. In 2022, the total value dropped but less than the DOW or S&amp;P. The dividends kept on coming without missing a beat. High risk they say, high rewards I say. It allows me to spend winters in Florida and yearly overseas vacations. I have zero regrets,&#8221; the retiree said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Small Cap

Personal Finance

ARCC

BXSL

CSWC

FDUS

GBDC

JEPI

JEPQ

MAIN

MPLX

OBDC

SCHD

SPYI

62-Year-Old With $400K And 8 Months To Retire Faces Huge Dilemma – 'How Would You Invest $400K?' Redditors Debate Best Low-Risk Moves

<a href="https://www.benzinga.com/personal-finance/25/01/43303778/bill-gates-says-this-book-on-ai-will-change-every-industry-predicts-millions-of-jobs-will-vanish-by-2030">Bill Gates</a> once expressed a deep concern about Microsoft&#8217;s future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) when he stepped down as CEO in 2000. He worried the company might lose its famed standard of excellence and that the chance to guide it back might one day be missed.&nbsp;
Even as he moved toward focusing on his philanthropic work, those early misgivings lingered in his mind. Despite the anxiety, Microsoft has charted an impressive course over the years.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>
<h2 class="wp-block-heading">Leadership That Transformed a Giant</h2>
Gates' fears eventually proved unnecessary. Steve Ballmer, who steered the company from 2000 until 2014, pushed Microsoft to unprecedented heights, setting the stage for the current era under Satya Nadella. He has been at the helm since 2014.
A look at the numbers reveals the scale of the transformation. According to <a href="https://www.statmuse.com/money/ask/microsoft-market-cap-historical">Statmuse</a>, Microsoft&#8217;s market capitalization reached $3.1 trillion on Dec. 31. Moreover, <a href="https://www.microsoft.com/investor/reports/ar24/index.html?utm_">Microsoft's annual reports</a> show that the company pulled in over $245 billion in annual revenue for fiscal 2024, a 16% jump from the previous year.
These milestones paint a picture of a company that met and exceeded early expectations. Gates hasn&#8217;t entirely stepped away. In a <a href="https://www.wsj.com/tech/bill-gates-interview-5-things-e11c3fa2">Wall Street Journal interview</a> on Jan. 26, he said, "I love doing product reviews, and [Satya Nadella] brings me in to do that." He added that while that's only 15% of his time, it helps him stay up to date, particularly in artificial intelligence, where Microsoft has made major moves.&nbsp;
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
This ongoing involvement allows him to harness the company&#8217;s vast resources to support the philanthropic foundation he co-founded with his ex-wife, Melinda French Gates. Though he left the CEO chair in 2000 and the board in 2020, his role as an advisor remains influential in shaping the company&#8217;s future.
Adding a dose of counterbalance to the success story, some industry experts see potential challenges ahead. Gil Luria, senior analyst at D.A. Davidson, said that Microsoft&#8217;s hefty investment in artificial intelligence—an $80 billion initiative scheduled for 2025—coupled with economic uncertainties, could pose risks, <a href="https://www.reuters.com/technology/artificial-intelligence/microsofts-costs-focus-fears-rise-over-slow-payoff-ai-2024-07-29">Reuters</a> reported.
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
According to<a href="https://www.marketwatch.com/story/microsoft-has-been-the-worst-big-tech-stock-lately-heres-why-it-may-become-the-best-c0e5794e"> MarketWatch</a>, Luria's Neutral rating with a $425 target reflects the idea that while Microsoft&#8217;s track record is impressive, the optimal moment for investors might still be ahead.
On Jan. 29, Microsoft's stock fell 4.5% in after-hours trading after the company forecast slower growth in its Azure cloud computing division and faced concerns over rising AI-related expenditures, according to <a href="https://www.reuters.com/technology/microsoft-beats-quarterly-revenue-estimates-2025-01-29/">Reuters</a>.&nbsp;
The company's capital expenditures reached $22.6 billion, exceeding analyst expectations and raising questions about near-term financial returns. Additionally, growing competition from lower-cost AI models developed by Chinese firms has fueled concerns about Microsoft's ability to monetize its <a href="https://www.benzinga.com/news/25/02/43903135/ais-19-9-trillion-impact-could-create-the-first-trillionaire-but-mark-cuban-says-it-wont-be-musk-or-bezos">AI</a> investments effectively.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

MSFT

Bill Gates Says He Feared Microsoft Would Struggle Without Him—Now It's Worth $3 Trillion And Thriving

Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) has outperformed the market over the past 15 years by 10.81% on an annualized basis producing an average annual return of 21.64%. Currently, Molina Healthcare has a market capitalization of $17.66 billion. 
Buying $1000 In MOH: If an investor had bought $1000 of MOH stock 15 years ago, it would be worth $18,894.85 today based on a price of $322.85 for MOH at the time of writing.
<h3>Molina Healthcare's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743205508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) has outperformed the market over the past 20 years by 1.52% on an annualized basis producing an average annual return of 9.56%. Currently, Brinker International has a market capitalization of $6.45 billion. 
Buying $100 In EAT: If an investor had bought $100 of EAT stock 20 years ago, it would be worth $628.93 today based on a price of $145.22 for EAT at the time of writing.
<h3>Brinker International's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743204639_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Brinker International 20 Years Ago Would Be Worth Today

Gold Fields (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>) has outperformed the market over the past 10 years by 7.47% on an annualized basis producing an average annual return of 17.88%. Currently, Gold Fields has a market capitalization of $19.69 billion. 
Buying $1000 In GFI: If an investor had bought $1000 of GFI stock 10 years ago, it would be worth $5,155.29 today based on a price of $22.00 for GFI at the time of writing.
<h3>Gold Fields's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743203708_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Gold Fields 10 Years Ago Would Be Worth This Much Today

Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) has outperformed the market over the past 5 years by 1.08% on an annualized basis producing an average annual return of 17.69%. Currently, Qualcomm has a market capitalization of $168.60 billion. 
Buying $100 In QCOM: If an investor had bought $100 of QCOM stock 5 years ago, it would be worth $221.24 today based on a price of $152.44 for QCOM at the time of writing.
<h3>Qualcomm's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743202814_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

QCOM

Here's How Much You Would Have Made Owning Qualcomm Stock In The Last 5 Years

FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) has outperformed the market over the past 5 years by 57.6% on an annualized basis producing an average annual return of 74.21%. Currently, FTAI Aviation has a market capitalization of $11.51 billion. 
Buying $100 In FTAI: If an investor had bought $100 of FTAI stock 5 years ago, it would be worth $1,620.47 today based on a price of $112.27 for FTAI at the time of writing.
<h3>FTAI Aviation's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743201909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FTAI

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

LLY RISES 8 POINTS AFTER ALERT
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/28202809/Screenshot-2025-03-28-at-4.24.08%E2%80%AFPM-996x1024.png" alt="" class="wp-image-9235" /></figure>
Eli Lilly &amp; Co. (LLY) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:33 AM on March 28th, a significant trading signal occurred for Eli Lilly &amp; Co. (LLY) as it demonstrated a Power Inflow at a price of $821.70. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Lilly&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Lillys stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for LLY, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like&nbsp; &nbsp; <a href="https://www.tradepulse.net">https://www.tradepulse.net</a>&nbsp; which are responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:The price at the time of the Power Inflow was $821.70. The returns on the High price ($829.78) and Close price ($822.51) after the Power Inflow are respectively 1.0% and 0.1%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your appetite for risk.
Past Performance is not indicative of future results

Equities

Technicals

Opinion

Signals

Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop

Kinsale Cap Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) has outperformed the market over the past 5 years by 19.16% on an annualized basis producing an average annual return of 35.76%. Currently, Kinsale Cap Gr has a market capitalization of $11.35 billion. 
Buying $1000 In KNSL: If an investor had bought $1000 of KNSL stock 5 years ago, it would be worth $4,503.88 today based on a price of $487.40 for KNSL at the time of writing.
<h3>Kinsale Cap Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743201009_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KNSL

$1000 Invested In Kinsale Cap Gr 5 Years Ago Would Be Worth This Much Today

Glaukos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) has outperformed the market over the past 5 years by 10.4% on an annualized basis producing an average annual return of 27.01%. Currently, Glaukos has a market capitalization of $5.83 billion. 
Buying $1000 In GKOS: If an investor had bought $1000 of GKOS stock 5 years ago, it would be worth $3,057.55 today based on a price of $103.15 for GKOS at the time of writing.
<h3>Glaukos's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743200109_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GKOS

Here's How Much You Would Have Made Owning Glaukos Stock In The Last 5 Years

Wall Street stumbled Friday as investors hustled to reevaluate their expectations with a hotter-than-anticipated inflation report and growing worries about imminent trade tariffs. <a href="https://www.benzinga.com/etfs">ETFs tracking the broad indexes</a> S&amp;P500 and Nasdaq 100, like SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), The iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>) and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), suffered losses as traders processed the most recent inflation reading and an alarming consumer sentiment report.
Inflation Halts Advancements Toward Rate Reduction
The Fed&#8217;s favored measure of inflation, the Personal Consumption Expenditures (PCE) price gauge, <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44535109/feds-favorite-inflation-gauge-rises-more-than-expected-in-february-casting-doubt-on-near-term-rate-cuts">rose 2.5% from the prior year, as expected</a>. Yet the core PCE that is watched most closely, adjusting for fidgety food and energy prices, gained 2.8%, beating expectations of 2.7% and its hottest level in more than a year.
LPL Financial chief economist Jeffrey Roach added that the increase in the core PCE print highlights <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44542821/inflation-will-accelerate-in-coming-months-if-april-2-tariffs-take-effect-economist-warns">lingering inflationary pressure</a>. He cited the rising savings rate, which hit 4.6%, as a sign that consumers are increasingly conservative about the outlook of the economy.
Comerica Bank&#8217;s chief economist, Bill Adams, seconded these fears, calling for a deceleration in consumer spending to weigh on real GDP growth in the first quarter of 2025. 
Also Read:<a href="https://www.benzinga.com/25/03/44545009/big-moves-at-intelthese-3-etfs-stand-to-benefit"> Big Moves At Intel: These 3 ETFs Stand To Benefit</a>
Market Sell-Off: SPY, IVV And QQQ Take The Brunt
The <a href="https://www.benzinga.com/topic/inflation">latest inflation figures</a> fueled a widespread sell-off on Wall Street on Friday, as all three major indexes lost heavily. S&amp;P 500 lost 2%, with the Nasdaq 100 losing 2.6%. Consequently, the SPY, an ETF that follows the S&amp;P 500, lost 2%, with QQQ, which follows the tech-heavy Nasdaq 100, losing 2.6% on Friday. IVV, another major ETF tracking the S&amp;P 500, also slumped 2%.
Tech stocks were hammered, with all of the <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44542620/inflation-fears-spark-risk-off-sentiment-as-magnificent-7-drop-whats-driving-markets-friday">Magnificent Seven trading in the red</a>. Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) led the decline, dropping 4.3% and 4.9%, respectively. Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), one of the highest holdings in SPY, wiped out its previous day&#8217;s gain, falling 3.4%.
Outlook: Volatility On The Horizon For SPY And QQQ
As inflation remained stickier than expected and the Federal Reserve increasingly under pressure to maintain higher rates, volatility in SPY and QQQ can be expected to continue. The slowdown in consumer spending, coupled with higher inflation and trade uncertainties, has created a vulnerable setup for the equity markets.
Though steady real disposable income growth could be a short-term buffer, as analyst Roach cautioned, any deceleration in pay growth would present an even bigger threat to the overall economy. Investors now look to the Federal Reserve&#8217;s next steps and the next steps in tariffs for more guidance in this uncharted economic climate.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44544012/auto-etfs-tumble-after-trumps-25-import-tariff-move-on-vehicles-made-overseas">Auto ETFs Tumble After Trump&#8217;s 25% Import Tariff Move On Vehicles Made Overseas</a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

ETFs

AMZN

GOOGL

TSLA

Sticky Inflation Weighs On Markets — SPY, QQQ, Tech Stocks Take A Hit

In the current session, the stock is trading at $35.75, after a 0.22% increase. Over the past month, CenterPoint Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) stock increased by 5.44%, and in the past year, by 27.55%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1743199227_0.png" alt="Past Year Chart" />

<h3>CenterPoint Energy P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 69.68 in the Multi-Utilities industry, CenterPoint Energy Inc. has a lower P/E ratio of 22.58. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743199227_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

A Look Into CenterPoint Energy Inc's Price Over Earnings

Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) has outperformed the market over the past 5 years by 8.79% on an annualized basis producing an average annual return of 25.4%. Currently, Exxon Mobil has a market capitalization of $510.07 billion. 
Buying $100 In XOM: If an investor had bought $100 of XOM stock 5 years ago, it would be worth $313.95 today based on a price of $117.55 for XOM at the time of writing.
<h3>Exxon Mobil's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743199209_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Exxon Mobil 5 Years Ago Would Be Worth Today

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) has outperformed the market over the past 10 years by 6.6% on an annualized basis producing an average annual return of 17.01%. Currently, S&amp;P Global has a market capitalization of $154.11 billion. 
Buying $1000 In SPGI: If an investor had bought $1000 of SPGI stock 10 years ago, it would be worth $4,789.92 today based on a price of $502.51 for SPGI at the time of writing.
<h3>S&amp;P Global's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743198308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SPGI

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) has outperformed the market over the past 10 years by 33.6% on an annualized basis producing an average annual return of 44.01%. Currently, Advanced Micro Devices has a market capitalization of $167.13 billion. 
Buying $100 In AMD: If an investor had bought $100 of AMD stock 10 years ago, it would be worth $3,837.17 today based on a price of $102.99 for AMD at the time of writing.
<h3>Advanced Micro Devices's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743197418_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Advanced Micro Devices 10 Years Ago Would Be Worth Today

<h2 class="wp-block-heading">Charlie Javice Found Guilty Of Defrauding JPMorgan Chase&nbsp;</h2>
Charlie Javice was convicted on Friday of defrauding JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) in its $175 million acquisition of the student<a href="https://www.benzinga.com/25/02/43794325/jp-morgans-acquisition-of-student-loan-start-up-falls-out-founder-in-court-for-alleged-fraud-ceo-jamie-dimon-calls-it-a-huge-mistake"> finance startup Frank.&nbsp;</a>
According to a Bloomberg<a href="https://www.bloomberg.com/news/articles/2025-03-28/charlie-javice-convicted-of-defrauding-jpmorgan-in-startup-deal"> report</a>, a Manhattan federal jury determined that the 32-year-old entrepreneur falsified user data to inflate Frank's customer base from fewer than 300,000 to over 4.25 million, misleading the bank into the acquisition.
The jury reached its decision after roughly six hours of deliberation. Javice now faces a potential maximum sentence of 30 years for bank fraud, though legal experts anticipate a lesser term. Sentencing will occur at a later date.
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/03/44537429/cathie-wood-doubles-down-on-2600-tesla-stock-price-prediction">Cathie Wood Doubles Down On $2,600 Tesla Stock Price Prediction</a>
<h2 class="wp-block-heading">Philadelphia Man Sentenced To 15 ½ Years In Prison For Investment Fraud Scheme</h2>
Joseph LaForte, a Philadelphia businessman, <a href="https://www.justice.gov/opa/pr/operator-fraudulent-investment-vehicle-sentenced-over-15-years-prison-securities-fraud-tax">was sentenced</a> to 15 and a half years in prison on Thursday for orchestrating a massive investment fraud scheme through Par Funding while evading millions in taxes. 
As CEO of Complete Business Solutions Group (operating as Par Funding), he defrauded investors of $404 million through a racketeering conspiracy involving securities and wire fraud. The scheme promised investors returns of 12% to 44% on merchant cash advance notes while diverting funds through sham contracts.
LaForte's tax crimes included hiding $20 million in Par Funding income through shell entities, failing to report $9 million in kickbacks and paying employees under the table to avoid employment taxes which resulted in $8 million in federal tax losses.&nbsp;
He also falsified residency to dodge $1.6 million in Pennsylvania state taxes. His brother James, Par Funding's &#8220;enforcer,&#8221; received an 11 and a half year sentence on March 13 for related crimes, including assaulting a court-appointed receiver's attorney.
The case was prosecuted by the U.S. Attorney's Office for the Eastern District of Pennsylvania following investigations by the IRS, FBI, and FDIC. LaForte forfeited assets including a private jet and was ordered to pay $314 million in restitution
Read Next:<a href="https://www.benzinga.com/government/regulations/25/03/44517885/trump-slaps-25-tariffs-on-autos-what-it-means-for-your-next-car-purchase">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44517885/trump-slaps-25-tariffs-on-autos-what-it-means-for-your-next-car-purchase">Trump Slaps 25% Tariffs On Autos: What It Means For Your Next Car Purchase</a> </li>
</ul>
Image: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Legal

Financial Crime Weekly: Charlie Javice Convicted Of Fraud In JPMorgan Acquisition Case, Man Sentenced To 15 Years For Investment Fraud

Motorola Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) has outperformed the market over the past 5 years by 10.04% on an annualized basis producing an average annual return of 26.64%. Currently, Motorola Solns has a market capitalization of $72.28 billion. 
Buying $1000 In MSI: If an investor had bought $1000 of MSI stock 5 years ago, it would be worth $3,246.53 today based on a price of $432.99 for MSI at the time of writing.
<h3>Motorola Solns's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743196509_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Motorola Solns 5 Years Ago Would Be Worth This Much Today

<h3>Gainers</h3>
<ul>
<li>Harte-Hanks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HHS#NASDAQ">HHS</a>) stock rose 17.8% to $5.5 during Friday's after-market session. The market value of their outstanding shares is at $40.4 million. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock increased by 16.62% to $0.09. The market value of their outstanding shares is at $4.8 million. </li>
<li>Mega Matrix (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MPU#AMEX">MPU</a>) stock moved upwards by 7.93% to $0.68. The company's market cap stands at $27.6 million. </li>
<li>IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) shares increased by 6.16% to $2.24. The market value of their outstanding shares is at $38.0 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) stock increased by 4.77% to $0.54. The market value of their outstanding shares is at $7.3 million. </li>
<li>So-Young Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) shares increased by 4.59% to $0.9. The market value of their outstanding shares is at $92.2 million. The company's, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Stran &amp; Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWAG#NASDAQ">SWAG</a>) shares decreased by 13.5% to $0.9 during Friday's after-market session. The company's market cap stands at $16.7 million. </li>
<li>Lytus Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYT#NASDAQ">LYT</a>) shares decreased by 12.73% to $0.09. The company's market cap stands at $1.9 million. </li>
<li>Oriental Culture Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) shares declined by 12.31% to $2.28. The market value of their outstanding shares is at $42.3 million. </li>
<li>Intelligent Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTJ#NASDAQ">INTJ</a>) shares fell 6.94% to $0.6. The market value of their outstanding shares is at $7.8 million. </li>
<li>AirNet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) stock declined by 5.87% to $0.36. The market value of their outstanding shares is at $5.2 million. </li>
<li>Kuke Music Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KUKE#NYSE">KUKE</a>) stock decreased by 5.54% to $2.73. The market value of their outstanding shares is at $19.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ANTE

ASST

INTJ

IZEA

KUKE

SWAG

12 Communication Services Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) shares rose 11.9% to $0.75 during Friday's after-market session. The company's market cap stands at $108.8 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares moved upwards by 10.96% to $0.81. The market value of their outstanding shares is at $2.2 million. </li>
<li>Gelteq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) shares increased by 10.0% to $1.1. The market value of their outstanding shares is at $10.3 million. </li>
<li>bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) stock increased by 9.8% to $4.48. The company's market cap stands at $43.6 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) shares increased by 9.75% to $4.5. The market value of their outstanding shares is at $165.9 million. </li>
<li>Century Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) shares rose 8.89% to $0.56. The market value of their outstanding shares is at $48.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) shares fell 20.5% to $0.02 during Friday's after-market session. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock fell 16.83% to $0.17. The market value of their outstanding shares is at $2.2 million. </li>
<li>23andMe Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) stock decreased by 14.57% to $0.52. The market value of their outstanding shares is at $13.8 million. </li>
<li>Enzo Biochem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENZ#NYSE">ENZ</a>) shares decreased by 14.26% to $0.37. The market value of their outstanding shares is at $19.3 million. </li>
<li>Qualigen Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLGN#NASDAQ">QLGN</a>) stock decreased by 13.39% to $3.3. The company's market cap stands at $2.4 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) shares fell 11.95% to $0.06. The market value of their outstanding shares is at $7.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDSX

BLUE

GCTK

GELS

IPSC

LGMK

MOLN

OCEA

Qualigen Therapeutics, Inc. - Common Stock

QLGN

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Xos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOS#NASDAQ">XOS</a>) stock increased by 14.5% to $3.94 during Friday's after-market session. The company's market cap stands at $31.6 million. As per the press release, Q4 earnings came out today. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock rose 12.86% to $2.63. The company's market cap stands at $87.8 million. </li>
<li>Lichen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) shares moved upwards by 10.84% to $4.43. The company's market cap stands at $2.6 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock moved upwards by 10.53% to $0.24. The company's market cap stands at $46.6 million. </li>
<li>DLH Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLHC#NASDAQ">DLHC</a>) stock moved upwards by 7.14% to $4.5. The company's market cap stands at $64.7 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares rose 7.08% to $0.13. The market value of their outstanding shares is at $17.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Multi Ways Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MWG#AMEX">MWG</a>) shares fell 10.6% to $0.29 during Friday's after-market session. The market value of their outstanding shares is at $9.5 million. </li>
<li>SUNation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) shares declined by 9.88% to $0.36. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock declined by 7.5% to $0.74. The market value of their outstanding shares is at $3.1 million. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) shares declined by 7.15% to $1.43. The market value of their outstanding shares is at $105.4 million. </li>
<li>Heramba Electric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) stock fell 6.78% to $0.25. The market value of their outstanding shares is at $11.2 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares declined by 4.77% to $1.0. The company's market cap stands at $17.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

ProKidney

Noticias

Últimas noticias sobre ProKidney (NASDAQ:PROK) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL